文献速递中毒与环境急症消化、代谢与肾脏急症

俄勒冈州毒品非刑事化、芬太尼与致死性过量用药

Drug Decriminalization, Fentanyl, and Fatal Overdoses in Oregon.
PubMed 文献 · JAMA Netw Open · 2024-09-03
一句话结论在调整芬太尼在非法毒品市场的快速传播后,俄勒冈州第110号措施(毒品非刑事化)与致死性药物过量率无关联(估计值[SE],-0.51[0.61];P=0.41)。

这项队列研究采用矩阵补全合成控制法,以美国48个州及华盛顿特区为对照,评估俄勒冈州2021年2月1日生效的第110号措施(M110,个人使用少量任何毒品非刑事化)与致死性药物过量率的关系。未调整时,非刑事化与每10万人每半年致死性过量率呈正相关(估计值[SE],1.83[0.47];P<.001);调整芬太尼在非法毒品市场传播这一混杂因素后,效应量方向改变(估计值[SE],-0.51[0.61];P=0.41),不再存在关联,敏感性分析结果一致。作者结论认为,未来评估毒品政策健康效应时应考虑非法毒品市场成分的变化。

要点

  • 俄勒冈州芬太尼在非法毒品供应中的快速传播发生在2021年上半年,与M110实施同期。
  • 未调整芬太尼传播时,毒品非刑事化与每10万人每半年致死性过量率呈正相关(估计值[SE],1.83[0.47];P<.001)。
  • 调整芬太尼传播作为混杂因素后,效应量方向改变(估计值[SE],-0.51[0.61];P=0.41),非刑事化与过量死亡无关联。
  • 敏感性分析结果与主要分析一致。
  • 作者认为,未来评估毒品政策健康效应时应考虑非法毒品市场成分的变化。

适用人群与场景

  • 研究纳入美国俄勒冈州及48个州和华盛顿特区,死亡数据来自美国疾病控制与预防中心2008年1月1日至2022年12月31日。
  • 对照组为48个美国州和华盛顿特区,均未实施毒品非刑事化。

诊断标准与关键阈值

  • 暴露定义为俄勒冈州第110号措施于2021年2月1日生效。
  • 芬太尼快速传播通过国家法医实验室信息系统报告的州级样本中芬太尼或其类似物所占百分比确定,变化点分析确定各州芬太尼快速升级时间。

研究设计与关键结果

  • 研究类型为队列研究,采用矩阵补全合成控制法分析致死性过量与M110实施的关系;对照组为48个美国州和华盛顿特区。
  • 主要结局为每半年每10万人致死性药物过量率。
  • 俄勒冈州非法毒品供应中芬太尼快速传播发生在2021年上半年,与M110实施同期。
  • 未调整时,毒品非刑事化与每10万人每半年致死性过量率呈正相关(估计值[SE],1.83[0.47];P<.001)。
  • 调整芬太尼传播作为混杂因素后,效应量方向改变(估计值[SE],-0.51[0.61];P=0.41),非刑事化与过量死亡无关联。
  • 敏感性分析结果与主要分析一致。
  • 数据分析于2023年秋季至2024年春季进行。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,未来评估毒品政策健康效应时应考虑非法毒品市场成分的变化。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: With the implementation of Measure 110 (M110) in 2021, Oregon became the first US state to decriminalize small amounts of any drug for personal use. To date, no analysis of the association of this law with overdose mortality has fully accounted for the introduction of fentanyl-a substance that is known to drive fatal overdose-to Oregon's unregulated drug market.

OBJECTIVE: To evaluate whether the decriminalization of drug possession in Oregon was associated with changes in fatal drug overdose rates after accounting for the rapid spread of fentanyl in Oregon's unregulated drug market.

DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, the association between fatal overdose and enactment of M110 was analyzed using a matrix completion synthetic control method. The control group consisted of the 48 US states and Washington, DC, all of which did not decriminalize drugs. The rapid spread of fentanyl in unregulated drug markets was determined using the state-level percentage of all samples reported to the National Forensic Laboratory Information System that were identified as fentanyl or its analogues. Mortality data were obtained from the Centers for Disease Control and Prevention for January 1, 2008, to December 31, 2022. Data analysis was performed from fall 2023 through spring 2024.

EXPOSURES: Measure 110 took effect in Oregon on February 1, 2021.

MAIN OUTCOMES AND MEASURES: The primary outcome assessed was fatal drug overdose rates per half-year. A changepoint analysis also determined when each state experienced a rapid escalation of fentanyl in its unregulated drug market.

RESULTS: In this analysis, rapid spread of fentanyl in Oregon's unregulated drug supply occurred in the first half of 2021, contemporaneous with enactment of M110. A positive crude association was found between drug decriminalization and fatal overdose rate per 100 000 per half year (estimate [SE], 1.83 [0.47]; P < .001). After adjusting for the spread of fentanyl as a confounder, the effect size changed signs (estimate [SE], -0.51 [0.61]; P = .41) and there was no longer an association between decriminalization and overdose mortality in Oregon. Sensitivity analyses were consistent with this result.

CONCLUSIONS AND RELEVANCE: In this cohort study of fatal drug overdose and the spread of fentanyl through Oregon's unregulated drug market, no association between M110 and fatal overdose rates was observed. Future evaluations of the health effects of drug policies should account for changes in the composition of unregulated drug markets.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Zoorob MJ, Park JN, Kral AH, et al. Drug Decriminalization, Fentanyl, and Fatal Overdoses in Oregon. JAMA Netw Open. 2024. PMID: 39235814. doi:10.1001/jamanetworkopen.2024.31612

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。